Gene: LRRC37A3
Official Full Name: leucine rich repeat containing 37 member A3provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16462 | LRRC37A3 Knockout cell line (HeLa) | Human | LRRC37A3 | 1:3~1:6 | Negative | Online Inquiry |
KO16463 | LRRC37A3 Knockout cell line (HCT 116) | Human | LRRC37A3 | 1:2~1:4 | Negative | Online Inquiry |
KO16464 | LRRC37A3 Knockout cell line (HEK293) | Human | LRRC37A3 | 1:3~1:6 | Negative | Online Inquiry |
KO16465 | LRRC37A3 Knockout cell line (A549) | Human | LRRC37A3 | 1:3~1:4 | Negative | Online Inquiry |
LRRC37A3 Gene Knockout Cell Lines are specifically engineered cell lines in which the LRRC37A3 gene has been effectively inactivated. This genetic alteration allows researchers to investigate the biological roles and pathways regulated by LRRC37A3, a gene implicated in various cellular processes, including immune response and cellular signaling. By creating a stable knockout model, scientists can explore the phenotypic consequences of LRRC37A3 deletion, providing insight into its function in both physiological and pathological conditions.
The core mechanism underlying the utility of these knockout cell lines lies in their capacity to elucidate the gene's contributions to cellular behaviors when challenged with various stimuli or drugs. The absence of LRRC37A3 alters standard signaling pathways, enabling researchers to identify compensatory mechanisms or other molecular interactions that may occur in its absence. This makes the cell lines invaluable for drug discovery, biomarker identification, and pathway elucidation.
In the context of research and clinical applications, LRRC37A3 Gene Knockout Cell Lines serve as critical tools for understanding the gene's involvement in diseases such as cancer and autoimmune disorders. Their importance is particularly pronounced in translational medicine, where insights gleaned from these models can lead to the development of novel therapeutic strategies and interventions.
What sets our LRRC37A3 Gene Knockout Cell Lines apart from alternatives is their rigorously validated genetic modification, characterized by high specificity and reproducibility. Researchers can rely on these models to provide consistent results, fostering confidence in experimental outcomes. Additionally, our offering comes with comprehensive support and protocols designed to facilitate seamless integration into existing workflows.
For researchers and clinicians focused on advancing their understanding of gene function and its implications in disease, our LRRC37A3 Gene Knockout Cell Lines represent a valuable asset. Our company boasts extensive expertise in biological product development, ensuring that each product is backed by thorough characterization and quality control. Embracing innovation and scientific rigor, we are committed to enabling breakthroughs in molecular and cellular research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.